|By PR Newswire||
|April 17, 2014 03:17 AM EDT||
DUBLIN, April 17, 2014 /PRNewswire/ --
Dublin - Research and Markets (http://www.researchandmarkets.com/research/8m2cpn/global_glycated) has announced the addition of the "Global Glycated Hemoglobin Testing Market Report" report to their offering.
(Logo: http://photos.prnewswire.com/prnh/20130307/600769 )
The analysts forecast the Global Glycated Hemoglobin Testing market to grow at a CAGR of 10.10 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing incidence of diabetes. The Global Glycated Hemoglobin Testing market has also been witnessing the growing use of point of care hemoglobin A1c testing. However, the presence of substitutes could pose a challenge to the growth of this market.
The report, the Global Glycated Hemoglobin Testing Market Report, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Glycated Hemoglobin Testing market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
POC HbA1c testing is an emerging trend in the Diagnostics Testing industry. The unavailability of spontaneous HbA1c test results is likely to affect the clinical decision making process, leading to delayed initiation of and adjustment to diabetes treatments. The failure to properly adjust treatments may cause patient incompliance and increase the risk of complications arising from the disease.
Physicians are currently embracing POC HbA1c testing methods, in order to improve patient care and ensure speedy availability of HbA1c results during a patient visit. In addition, POC tests provide patient comfort and standardized laboratory-quality results that are easy to use. Hence, the growing use of POC HbA1c testing is becoming a significant tool for physicians to monitor and effectively treat diabetic patients.
According to the report, one of the major drivers in the market is the increasing incidence of diabetes among the population, creating a need for HbA1c testing methods to diagnose and monitor diabetes.
Further, the report states that one of the key challenges confronting the market is the presence of substitutes such as glucose meters, test strips, lancets, and continuous blood glucose meters, which are used to monitor diabetes.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Key Topics Covered:
01. Executive Summary
02. Scope of the Report
03. Market Research Methodology
04. List of Abbreviations
06. Market Landscape
07. Market Segmentation by Criteria
08. Market Segmentation by Method
09. Geographical Segmentation
10. Buying Criteria
11. Market Growth Drivers
12. Drivers and their Impact
13. Market Challenges
14. Impact of Drivers and Challenges
15. Market Trends
16. Trends and their Impact
17. Vendor Landscape
18. Key Vendor Analysis
19. Other Reports in this Series
- A. Menarini Diagnostics Ltd.
- ARKRAY Inc.
- Abbott Laboratories
- Alere Inc.
- Bayer AG
- Beckman Coulter Inc.
- Bio-Rad Laboratories Inc.
- Diazyme Laboratories Inc.
- Pointe Scientific Inc.
- Randox Laboratories Ltd.
- Roche Holdings AG
- Roche Holdings AG.
- Tosoh Corp.
- Trinity Biotech plc
For more information visit http://www.researchandmarkets.com/research/8m2cpn/global_glycated
Media Contact: Laura Wood , +353-1-481-1716, [email protected]
SOURCE Research and Markets